Tech Transfer eNews Blog

Amend Surgical licenses Harvard technology to improve oral surgery

By Jesse Schwartz
Published: July 29th, 2020

Amend Surgical, a Florida-based medical device company, has licensed a technology from the Wyss Institute for Biologically Inspired Engineering at Harvard University that could improve the quality of care in the field of oral surgery.

Created in the lab of Wyss researcher David Mooney, the technology is a biocompatible hydrogel-based material that forms a strong bond with biological tissues, even in difficult, wet environments such as the oral cavity. Amend plans to use the technology in products that release drugs or other active agents during wound closure, as well as patches that promote dentin restoration.

“It has been gratifying to watch this technology transform from a project in the lab into an innovation with real potential to help patients recover from surgery more comfortably,” says Mooney. “I’m proud of the work the team has done to successfully get it to this point, and look forward to further collaboration opportunities with Amend Surgical to see it make an impact in the clinic.”

Robby Lane, co-founder and CEO of Amend, comments, “Both our engineering and clinical teams were involved in the evaluation of this important technology, and we are eager to begin commercialization. We envision that the tough adhesive could provide clinicians both a wound barrier and an effective means to protect bone grafts in a single, easy-to-apply product, and could potentially eliminate the need for sutures used in conjunction with most dental barriers.”

The Harvard Office of Technology Development (OTD) facilitated the license agreement with Amend. Erika Bechtold, director of technology commercialization at OTD, comments, “We knew that the tough gel adhesive had enormous potential in a variety of internal and external wound closure applications, and the license with Amend Surgical in the oral surgery space is a great first application to leverage all of the unique advantages and features of this technology, beyond even its ability to bind to wet surfaces. It shows great promise for development into a range of possible products that would benefit both patients and their physicians.”

Source: Harvard University Office of Technology Development

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment